ClinicalTrials.govpublic full text
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
neoplasms, colon, colon cancer, mmrp, mss, dostarlimab, capeox, neoadjuvant, gsk4057190a, tsr-042, chemotherapy, immunotherapy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 895295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.